PHILADELPHIA--(BUSINESS WIRE)--The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. NDRI is one of more than 8,000 CAP-accredited biorepository facilities worldwide.
“NDRI is proud to have earned CAP Accreditation,” said Bill Leinweber, president and CEO of NDRI. “This accreditation is testament to the dedication and shared commitment of all of our staff to assuring that the gifts with which we are entrusted to advance biomedical research are managed with the highest scientific standards.”
“At NDRI, we are committed to the highest quality of service for the research community. We are extremely proud of our continued biorepository accreditation and the support it provides to our partners,” said Melissa VonDran, PhD, Vice President of Operations and Biorepository Director.
The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.
During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. NDRI was first accredited by CAP in 2016. Accreditations occur every three years.
About NDRI:
The National Disease Research Interchange (NDRI) is the nation’s leading source of human tissues, cells and organs for scientific research. A not-for-profit 501 (c) (3) organization founded in 1980, NDRI is funded in part by the National Institutes of Health, public and private foundations and organizations, pharmaceutical and biotechnology corporations. NDRI is a 24/7 operation that partners with a nationwide network of over 130 tissue source sites (TSS), including organ procurement organizations (OPOs), tissue banks, eye banks, and hospitals. The TSS, are distributed throughout the USA, in 45 states, with concentrations in major metropolitan areas on both the east and west coasts. Their wide geographic distribution allows NDRI to provide biospecimens from donor populations with diverse demographics and also facilitates the timely and efficient provision of fresh tissues directly to researchers across the U.S. and around the world. By serving as the liaison between procurement sources and the research community, NDRI is uniquely positioned to support breakthrough advances and discoveries that can affect advances in the treatment and cure of human diseases.
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.
